Zobrazeno 1 - 10
of 19
pro vyhledávání: '"V. A. Khaylenko"'
Autor:
Yu. S. Krumin, V. A. Khaylenko, N. A. Kozlov, G. Yu. Cheremis, A. V. Petrovskyy, D. V. Khaylenko, E. V. Artamonova, E. I. Kovalenko
Publikováno v:
Опухоли женской репродуктивной системы, Vol 16, Iss 4, Pp 41-45 (2021)
The article analyzes data from the world literature for the period from 2005 to 2020 on the relationship between the variability of immunohistochemical expression of estrogen and progesterone receptors, HER2/neu protein and the index of proliferative
Externí odkaz:
https://doaj.org/article/93d67d3d81b94437a420db27b23649ab
Publikováno v:
Опухоли женской репродуктивной системы, Vol 14, Iss 3, Pp 40-47 (2018)
Breast cancer is the 2nd most common malignant disease after lung cancer; about 1 in 8 women will develop breast cancer in her lifetime. Cancer progression is a serious complication of the disease that encourages comprehensive investigation of molecu
Externí odkaz:
https://doaj.org/article/8f7c84399b4142f8bc694790244149d5
Autor:
A. A. Bozhok, E. E. Topuzov, A. D. Zikiryakhodzhaev, A. S. Sukhot’ko, V. A. Khaylenko, Yu. S. Shatova, N. A. Klimov, Р. М. Палтуев
Publikováno v:
Опухоли женской репродуктивной системы, Vol 12, Iss 4, Pp 17-24 (2017)
In 11.5 % of breast cancer patients distant metastases are detected at diagnosis. The results of treatment of 608 patients of 5 Russian oncological centers are presented. Removal of the primary tumor in case of newly diagnosed advanced breast cancer
Externí odkaz:
https://doaj.org/article/b09533ac42bd447d85c63707eb234a07
Publikováno v:
Опухоли женской репродуктивной системы, Vol 12, Iss 3, Pp 36-42 (2016)
Breast cancer (BC) is the second most common type of cancer worldwide and affects 1 in 8 women over the course of their lifetime. A personalized approach to treating BC can substantially increase efficiency and consequently maintain the active life o
Externí odkaz:
https://doaj.org/article/73dbdc8b2d274a31a7c0cc9abcb5b61e
Publikováno v:
Опухоли женской репродуктивной системы, Vol 12, Iss 1, Pp 52-55 (2016)
This study evaluated the ability to perform organ-operation in breast cancer stage III. Highlight 2 similar groups of patients, depending on the extent of the procedure: in the 1st (main) were performed breast conserving surgery (BCS), in the 2nd (co
Externí odkaz:
https://doaj.org/article/4bce0c8e50144d868e5d8142d038f9ca
Autor:
L. N. Lyubchenko, Ye. I. Bateneva, I. K. Vorotnikov, S. M. Portnoy, O. V. Krokhina, V. A. Sobolevskiy, L. G. Zhukova, V. A. Khaylenko, S. A. Tyulyandin
Publikováno v:
Успехи молекулярной онкологии, Vol 1, Iss 2, Pp 16-25 (2015)
5–10 % of breast cancer cases are hereditary, 30 % of them are caused by BRCA1 and BRCA2 mutations (breast / ovarian cancer syndrome). Average cumulative risks of breast and ovarian cancer in BRCA1 mutation carriers run up to 87 % and 44 %, corresp
Externí odkaz:
https://doaj.org/article/a37c7e85850748e286b34152105d1818
Publikováno v:
Russian Journal of Oncology. 25:56-60
The most serious complication of breast cancer (BC), which affects life expectancy, is metastasis of the tumor. Metastasis is the cause of more than 80% of all breast cancer deaths. After surgical treatment and the use of adjuvant therapy, metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec700fe1026583b1fe30ec7d5a502ab2
https://doi.org/10.17816/1028-9984-2020-25-2-56-60
https://doi.org/10.17816/1028-9984-2020-25-2-56-60
Publikováno v:
Russian Journal of Oncology. 23:129-133
A serious complication of breast cancer is metastasis of tumor cells. The initiation of this process takes place in the nearby lymphatic vessels. To date, the molecular mechanisms of metastasis are not well understood and further research is required
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e3efcaece2cae9f9a4b1f17f979717e
https://doi.org/10.18821/1028-9984-2018-23-3-6-129-133
https://doi.org/10.18821/1028-9984-2018-23-3-6-129-133
Autor:
E. V. Chernova, V. A. Khaylenko, L. G. Zhukova, A. G. Abdullaev, D. V. Komov, L. N. Lyubchenko, A. V. Khaylenkо, N. E. Kudashkin, D. A. Burov
Publikováno v:
Onkourologiâ, Vol 14, Iss 3, Pp 128-132 (2018)
The main method of treatment of local stages of clear cell renal cancer is surgical. The question of conducting adjuvant irradiation and chemotherapy after radical operations is open. Patients with solitary distant metastases and a favorable prognosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38256a323bf2cd6c46bcfdab26826d2
https://doi.org/10.17650/1726-9776-2018-14-3-128-132
https://doi.org/10.17650/1726-9776-2018-14-3-128-132
Autor:
V. V Karaseva, Polina S. Feoktistova, V. A Khaylenko, O. A Sinelnikova, Olga Viktorovna Zharkova
Publikováno v:
Russian Journal of Oncology. 22:266-273
In recent years there has been strong progress in the treatment of metastatic colorectal cancer (mCRC) patients. The gain of the median of the overall survival (mOS) rate was more than doubled due to the introduction in the clinical practice of new c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::077c3770ec1e8832946208e811444503
https://doi.org/10.18821/1028-9984-2017-22-5-266-273
https://doi.org/10.18821/1028-9984-2017-22-5-266-273